Sign in
Taking peopleNo phase

Early versus later heparin to prevent blood clots after bleeding in the brain

Compares starting heparin earlier or later to prevent blood clots after brain hemorrhage.

Key facts

Who runs it
Pirogov Russian National Research Medical University
Where
Russia1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
Status
Recruiting
People taking part
200 people, planned
Started
21 Oct 2024
Expected to end
31 Dec 2028
Type of study
Interventional, 2 groups
Treatments tested
  • Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission.
  • Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission.
Record updated
24 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with bleeding inside the brain caused by high blood pressure (hypertensive intracerebral hemorrhage). It compares an early and a later start of heparin to prevent blood clots in the veins.

Age
18 years and older
Sex
All sexes
Disease stage
Hypertensive intracerebral hemorrhage (bleeding in the brain caused by high blood pressure).
Earlier treatment
People cannot join if they took a blood thinner (anticoagulant) before or on the day they came to hospital. People cannot join if they had surgery for the brain bleed before heparin started.

Main reasons for not taking part

  • The brain bleed grew on a CT scan 12-24 hours after coming to hospital
  • Taking a blood thinner before or on the day of hospital admission
  • A blood clot in the veins found when coming to hospital
  • Surgery for the brain bleed before heparin started
  • Cancer at the time of hospital admission

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • the presence of hypertensive intracerebral hemorrhage

Who cannot take part

  • Intracerebral hemorrhage expansion detected on the basis of a computed tomography scan of the brain 12-24 hours after a hospital admission (i.e. before the initiation of venous thromboembolism prophylaxis with heparin)
  • Detection of venous thromboembolism in a patient at the moment of hospital admission
  • Surgical management of hypertensive intracerebral hemorrhage before the beginning of venous thromboembolism prophylaxis using heparin
  • The presence of a malignancy (cancer) in a patient at the moment of hospital admission
  • Being on an anticoagulant during preadmission period and on day of hospital admission
  • Death within the first 2 days after hospital admission

This trial is currently available in Russia.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this randomized clinical trial is to evaluate the safety and efficiency of different anticoagulation schemes with heparin for venous thromboembolism prevention in patients with hypertensive intracerebral hemorrhage. The main questions it aims to answer are:

Read full original descriptionShow less

* What is the optimal time for the beginning of anticoagulation with heparin to efficiently prevent venous thromboembolism in patients with hypertensive intracerebral hemorrhage? Early beginning (within the first 2 days but not earlier than 12 hours after the admission of a patient) or delayed beginning (on the third day after the admission of a patient)? * Which of the two timeframes (early or delayed) for anticoagulation beginning is the most safe in terms of bleeding complications including intracerebral hemorrhage expansion?

Researchers will compare the results of early and delayed start of anticoagulation using heparin in patients with hypertensive intracerebral hemorrhage to define the optimal start time for anticoagulation that provides the most favourable efficiency/safety profile.

Participants will:

* Undergo a computed tomography (CT) scan of the brain on hospital admission and then 12-24 hours after the hospital admission and 24 hours after the beginning of venous thromboembolism prophylaxis using heparin; * Undergo the ultrasound examination of lower extremity deep veins on hospital admission and then once every 7 days; * Receive prophylactic doses of low molecular weight heparin or unfractionated heparin either beginning within the first 2 days but not earlier than 12 hours after the hospital admission or starting on the 3rd day after the hospital admission.

The 2 groups in the trial

  • Early beginning of venous thromboembolism prophylaxis in patients with intracerebral hemorrhageTreatment being tested

    Participants will receive prophylactic doses of unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after the hospital admission. If a participant is diagnosed with venous thromboembolism after the initiation of venous thromboembolism prophylaxis with heparin, the participant might receive therapeutic doses of unfractionated heparin or low molecular weight heparin by the joint decision of neuroemergency specialist, neurologist, neurosurgeon and vascular surgeon.

    Treatment: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting within the first 2 days but not earlier than 12 hours after a hospital admission.

  • Delayed beginning of venous thromboembolism prophylaxis in patients with intracerebral hemorrhageTreatment being tested

    Participants will receive prophylactic doses of unfractionated heparin or low molecular weight heparin starting on the 3rd day after the hospital admission. If a participant is diagnosed with venous thromboembolism after the initiation of venous thromboembolism prophylaxis with heparin, the participant might receive therapeutic doses of unfractionated heparin or low molecular weight heparin by the joint decision of neuroemergency specialist, neurologist, neurosurgeon and vascular surgeon.

    Treatment: Venous thromboembolism prophylaxis with unfractionated heparin or low molecular weight heparin starting on the 3rd day after a hospital admission.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early or Delayed Initiation of Venous Thromboembolism Prophylaxis With Heparin in Patients With Hypertensive Intracerebral Hemorrhage
Plain-language title
Early versus later heparin to prevent blood clots after bleeding in the brainGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
24 March 2026